Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin J Blake

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Current Opinion in Critical Care|September 26, 2003
Inflammatory biomarkers of the patient with myocardial insufficiencyGavin J Blake
BMJ (Clinical Research Ed.)|June 23, 2012
The risks in risk predictionCatherine McGorrian, Gavin J Blake
Journal of the American College of Cardiology|March 20, 2003
C-reactive protein and other inflammatory risk markers in acute coronary syndromesGavin J Blake, Paul M Ridker
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|October 15, 2003
C-reactive protein: a surrogate risk marker or mediator of atherothrombosis?Gavin J Blake, Paul M Ridker
Current Controlled Trials in Cardiovascular Medicine|November 21, 2001
Are statins anti-inflammatory?Gavin J Blake, Paul M Ridker
Journal of Cardiovascular Electrophysiology|May 13, 2011
Carotid sinus massageEdmond M Cronin, Gavin J Blake
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2002
C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular eventsGavin J Blake, Paul M Ridker
The New England Journal of Medicine|January 11, 2008
Long-term follow-up of the West of Scotland Coronary Prevention StudyJohn W McEvoy, Ronan Margey, Gavin J Blake
Circulation. Heart Failure|January 20, 2011
Ruptured noncoronary sinus of valsalva aneurysm: an unusual cause of chronic right-sided heart failureEdmond M Cronin, Kevin P Walsh, Gavin J Blake
The American Journal of Medicine|May 3, 2003
Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemiaGavin J Blake, Paul M Ridker, Karen M Kuntz
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Current Opinion in Critical Care|September 26, 2003
Inflammatory biomarkers of the patient with myocardial insufficiencyGavin J Blake
BMJ (Clinical Research Ed.)|June 23, 2012
The risks in risk predictionCatherine McGorrian, Gavin J Blake
Journal of the American College of Cardiology|March 20, 2003
C-reactive protein and other inflammatory risk markers in acute coronary syndromesGavin J Blake, Paul M Ridker
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|October 15, 2003
C-reactive protein: a surrogate risk marker or mediator of atherothrombosis?Gavin J Blake, Paul M Ridker
Current Controlled Trials in Cardiovascular Medicine|November 21, 2001
Are statins anti-inflammatory?Gavin J Blake, Paul M Ridker
Journal of Cardiovascular Electrophysiology|May 13, 2011
Carotid sinus massageEdmond M Cronin, Gavin J Blake
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2002
C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular eventsGavin J Blake, Paul M Ridker
The New England Journal of Medicine|January 11, 2008
Long-term follow-up of the West of Scotland Coronary Prevention StudyJohn W McEvoy, Ronan Margey, Gavin J Blake
Circulation. Heart Failure|January 20, 2011
Ruptured noncoronary sinus of valsalva aneurysm: an unusual cause of chronic right-sided heart failureEdmond M Cronin, Kevin P Walsh, Gavin J Blake
The American Journal of Medicine|May 3, 2003
Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemiaGavin J Blake, Paul M Ridker, Karen M Kuntz
Pageof 3